| Accession Number: | 0001209191-22-025172 |
| Date: | 2022-04-19 |
| Issuer: | MYOVANT SCIENCES LTD. (MYOV) |
| Original Submission Date: |
MERENDINO LAUREN
C/O MYOVANT SCIENCES INC.
2000 SIERRA POINT PARKWAY, 9TH FLOOR
BRISBANE, CA 94005
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON SHARES | 2022-04-19 | S | 7,049 | d | $10.45 | 174,953 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in table i. |
| f2 | the shares were sold at prices ranging from $10.45 to $10.51. the reporting person will provide to the sec, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
